Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Incyte Corporation - Common Stock
(NQ:
INCY
)
104.15
-1.26 (-1.20%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,035,020
Open
104.57
Bid (Size)
103.82 (400)
Ask (Size)
107.00 (100)
Prev. Close
105.41
Today's Range
103.77 - 106.92
52wk Range
53.56 - 109.28
Shares Outstanding
222,430,635
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Fear Of An AI Bubble? This Sector Is Quietly Surging While Tech Sinks
↗
November 14, 2025
While AI stocks slide, healthcare is soaring. XLV leads November gains, outperforming tech as investors rotate.
Via
Benzinga
Topics
Artificial Intelligence
1 Mid-Cap Stock to Consider Right Now and 2 We Turn Down
November 13, 2025
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with...
Via
StockStory
Performance
YTD
+49.8%
+49.8%
1 Month
+18.9%
+18.9%
3 Month
+22.6%
+22.6%
6 Month
+63.2%
+63.2%
1 Year
+35.3%
+35.3%
More News
Read More
Peering Into Incyte Corp's Recent Short Interest
↗
November 12, 2025
Via
Benzinga
Incyte (NASDAQ:INCY) Q3 Earnings: Leading The Immuno-Oncology Pack
November 10, 2025
Via
StockStory
Topics
Artificial Intelligence
Winners And Losers Of Q3: Regeneron (NASDAQ:REGN) Vs The Rest Of The Immuno-Oncology Stocks
November 10, 2025
Via
StockStory
Topics
Artificial Intelligence
1 Cash-Producing Stock Worth Your Attention and 2 Facing Headwinds
November 06, 2025
Via
StockStory
Topics
Economy
Supply Chain
Incyte’s Moments of Clarity Program Expands to Highlight Powerful Patient Stories in Vitiligo and Pediatric Eczema
November 06, 2025
From
Incyte
Via
Business Wire
Incyte (INCY): Buy, Sell, or Hold Post Q3 Earnings?
November 05, 2025
Via
StockStory
Prelude Therapeutics Announces Exclusive Option Agreement with Incyte to Advance Mutant Selective JAK2V617F JH2 Inhibitors
November 04, 2025
From
Prelude Therapeutics, Incorporated
Via
GlobeNewswire
The 5 Most Interesting Analyst Questions From Incyte’s Q3 Earnings Call
November 04, 2025
Via
StockStory
Topics
Earnings
Stay informed with the top movers within the S&P500 index on Monday.
↗
November 03, 2025
Via
Chartmill
Kenvue, IDEXX Laboratories, Freshpet And Other Big Stocks Moving Higher On Monday
↗
November 03, 2025
Via
Benzinga
These S&P500 stocks have an unusual volume in today's session
↗
November 03, 2025
Via
Chartmill
Exploring the top movers within the S&P500 index during today's session.
↗
November 03, 2025
Via
Chartmill
Incyte Announces More than 50 Abstracts Accepted for Presentation at the 2025 ASH Annual Meeting
November 03, 2025
From
Incyte
Via
Business Wire
Incyte to Present at Upcoming Investor Conferences
October 30, 2025
From
Incyte
Via
Business Wire
INCY Q3 Deep Dive: Strong Product Momentum and Pipeline Reshaping Amid Strategic Refocus
October 29, 2025
Via
StockStory
Incyte Delivers Robust Growth, But 2028 Patent Expiry Still Looms
↗
October 28, 2025
Via
Benzinga
Topics
Intellectual Property
These S&P500 stocks have an unusual volume in today's session
↗
October 28, 2025
Via
Chartmill
Why Incyte (INCY) Stock Is Trading Lower Today
October 28, 2025
Via
StockStory
Nasdaq 100 Hits 26,000, Gold Falls Below $4,000: What's Moving Markets Tuesday?
↗
October 28, 2025
Via
Benzinga
Topics
Economy
Incyte (INCY) Q3 2025 Earnings Call Transcript
↗
October 28, 2025
Via
The Motley Fool
Topics
Earnings
Incyte Falls After Hiked 2025 Outlook Misses Wall Street's Bullish Views
↗
October 28, 2025
Via
Investor's Business Daily
Topics
Government
Incyte Corp (NASDAQ:INCY) Reports Strong Q3 2025 Earnings, Beating Estimates
↗
October 28, 2025
Via
Chartmill
Topics
Earnings
Incyte (NASDAQ:INCY) Reports Strong Q3
October 28, 2025
Via
StockStory
Topics
Artificial Intelligence
Frequently Asked Questions
Is Incyte Corporation - Common Stock publicly traded?
Yes, Incyte Corporation - Common Stock is publicly traded.
What exchange does Incyte Corporation - Common Stock trade on?
Incyte Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Incyte Corporation - Common Stock?
The ticker symbol for Incyte Corporation - Common Stock is INCY on the Nasdaq Stock Market
What is the current price of Incyte Corporation - Common Stock?
The current price of Incyte Corporation - Common Stock is 104.15
When was Incyte Corporation - Common Stock last traded?
The last trade of Incyte Corporation - Common Stock was at 11/14/25 04:00 PM ET
What is the market capitalization of Incyte Corporation - Common Stock?
The market capitalization of Incyte Corporation - Common Stock is 23.17B
How many shares of Incyte Corporation - Common Stock are outstanding?
Incyte Corporation - Common Stock has 23B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.